A cost-utility analysis of risk model-guided versus physician's choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach

Thavorn Kednapa; Coyle Doug; Hoch Jeffrey S.; Vandermeer Lisa; Mazzarello Sasha; Wang Zhou; Dranitsaris George; Fergusson Dean; Clemons Mark

首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >A cost-utility analysis of risk model-guided versus physician's choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach

【24h】

A cost-utility analysis of risk model-guided versus physician's choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach

机译：风险模型导向与医生选择止期乳腺癌患者止期疗效的成本实用性分析：净利润回归方法

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose We assessed the cost-effectiveness of a risk model-guided (RMG) antiemetic prophylaxis strategy compared with the physician's choice (PC) strategy in patients receiving chemotherapy for early-stage breast cancer.

机译：目的，我们评估了风险模型引导（RMG）止吐预防策略的成本效益与接受早期乳腺癌的化疗中的医生的选择（PC）策略相比。

著录项

来源
《Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer》 |2017年第8期|共9页
作者
Thavorn Kednapa; Coyle Doug; Hoch Jeffrey S.; Vandermeer Lisa; Mazzarello Sasha; Wang Zhou; Dranitsaris George; Fergusson Dean; Clemons Mark;
展开▼
作者单位

Ottawa Hosp Res Inst Gen Campus 501 Smyth Rd POB 201B Ottawa ON K1H 8L6 Canada;

Univ Ottawa Sch Epidemiol Publ Hlth &

Prevent Med Ottawa ON Canada;

Univ Calif Davis Dept Publ Hlth Sci Davis CA 95616 USA;

Univ Ottawa Div Med Oncol Ottawa ON Canada;

Univ Ottawa Div Med Oncol Ottawa ON Canada;

Univ Waterloo Dept Stat &

Actuarial Sci Waterloo ON Canada;

Ottawa Hosp Res Inst Gen Campus 501 Smyth Rd POB 201B Ottawa ON K1H 8L6 Canada;

Ottawa Hosp Res Inst Gen Campus 501 Smyth Rd POB 201B Ottawa ON K1H 8L6 Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类护理学;
关键词
Chemotherapy-induced nausea and vomiting; Risk model-guided antiemetic prophylaxis strategy; Early stage breast cancer; Economic evaluation; Net-benefit regression approach;

机译：化疗诱导的恶心和呕吐;风险模型引导的止吐预防预防策略;早期乳腺癌;经济评估;净效益回归方法;

相似文献

外文文献
中文文献
专利

1. A cost-utility analysis of risk model-guided versus physician's choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach [J] . Thavorn Kednapa, Coyle Doug, Hoch Jeffrey S., Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2017,第8期

机译：风险模型导向与医生选择止期乳腺癌患者止期疗效的成本实用性分析：净利润回归方法
2. A COST-UTILITY ANALYSIS OF THE RISK MODEL-GUIDED ANTIEMETIC PROPHYLAXIS VERSUS PHYSICIAN'S CHOICE IN PATIENTS RECEIVING CHEMOTHERAPY FOR EARLY-STAGE BREAST CANCER: A NET-BENEFIT REGRESSION APPROACH [J] . Thavorn K., Vandermeer L., Mazzarello S., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：接受早期乳腺癌化疗的患者中风险模型指导的抗药性脯酸对医师选择的成本效用分析：净收益回归方法
3. Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors [J] . Alena M Pfeil, Christof Vulsteke, Robert Paridaens, BMC Cancer . 2014,第1期

机译：接受化疗的早期乳腺癌患者发热性中性粒细胞减少症发生的多变量回归分析，评估患者相关，化疗相关和遗传危险因素
4. A side-effects mapping model in patients with lung, colorectal and breast cancer receiving chemotherapy [C] . Mazzocco Thomas, Hussain Amir 2011 IEEE 13th International Conference on e-Health Networking, Applications and Services . 2011

机译：肺癌，结直肠癌和乳腺癌患者接受化疗的副作用映射模型
5. Effects of primary prophylaxis of neutropenia on outcomes, utilization and expenditures for elderly breast cancer patients receiving chemotherapy. [D] . Rajan, Suja S. 2009

机译：一级预防中性粒细胞减少对老年接受化疗的乳腺癌患者的结局，利用和支出的影响。
6. Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related chemotherapy-related and genetic risk factors [O] . Alena M Pfeil, Christof Vulsteke, Robert Paridaens, 2014

机译：接受化疗的早期乳腺癌患者发热性中性粒细胞减少症发生的多变量回归分析评估患者相关化疗相关和遗传危险因素
7. A Cost-Utility Analysis of the Risk Model-Guided Antiemetic Prophylaxis Versus Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Net-Benefit Regression Approach [O] . K Thavorn, L Vandermeer, S Mazzarello, 2016

机译：风险模型引导止吐预防预防预防患者的成本实用性分析与早期乳腺癌接受化疗的患者：净利润回归方法

A cost-utility analysis of risk model-guided versus physician's choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach

摘要

著录项

相似文献

相关主题

期刊订阅